Trials / Completed
CompletedNCT03630770
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Joseph Bliss · Academic / Other
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
This study evaluates whether adding a dietary supplement similar to coconut oil (MCT oil) to feedings in premature infants will reduce the amount of yeast (Candida) detectable in their stool. Infants who have Candida in their stool are eligible to participate. Half of the enrolled infants will have additional MCT oil added to their feedings and half will not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Medium-Chain Triglyceride (MCT) Oil | Infants receive 0.5 ml/oz of MCT oil to their prescribed feedings for 21 days or until hospital discharge. |
Timeline
- Start date
- 2014-06-05
- Primary completion
- 2017-11-29
- Completion
- 2021-11-02
- First posted
- 2018-08-15
- Last updated
- 2022-06-14
- Results posted
- 2022-06-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03630770. Inclusion in this directory is not an endorsement.